Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
6.90T | 6.76T | 6.57T | 6.22T | 11.92T | 3.83T | Gross Profit |
3.63T | 3.54T | 3.33T | 3.27T | 9.17T | 1.24T | EBIT |
831.07B | 560.01B | 380.08B | 713.85B | 6.89T | -918.51B | EBITDA |
853.41B | 1.47T | 1.27T | 365.37B | 7.73T | 2.61T | Net Income Common Stockholders |
71.06B | -227.65B | -1.01T | -1.74T | 4.99T | -1.16T |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
6.78T | 6.19T | 7.11T | 5.36T | 4.78T | 3.61T | Total Assets |
44.98T | 46.72T | 43.94T | 47.54T | 45.75T | 37.26T | Total Debt |
20.93T | 21.36T | 20.73T | 22.82T | 20.04T | 14.77T | Net Debt |
14.77T | 15.18T | 13.80T | 17.65T | 15.38T | 11.40T | Total Liabilities |
33.27T | 33.49T | 33.70T | 36.33T | 34.29T | 30.38T | Stockholders Equity |
9.77T | 10.97T | 8.62T | 9.48T | 9.72T | 5.42T |
Cash Flow | Free Cash Flow | ||||
28.71B | -372.06B | 35.71B | -323.63B | -123.89B | -145.74B | Operating Cash Flow |
659.87B | 250.55B | 669.48B | 511.44B | 523.00B | 1.09T | Investing Cash Flow |
-1.72T | -841.46B | 228.18B | -3.06T | -16.86B | -4.37T | Financing Cash Flow |
-894.89B | -606.22B | 191.52B | 602.22B | 2.24T | 2.92T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $2.92T | 31.66 | 34.29% | 0.80% | 15.04% | 12.38% | |
78 Outperform | $2.06T | 20.39 | 32.91% | 0.35% | 13.89% | 38.99% | |
75 Outperform | $1.13T | 12.74 | 14.70% | ― | 1.91% | -6.72% | |
74 Outperform | $3.36T | 35.09 | 136.52% | 0.45% | 2.61% | -2.14% | |
73 Outperform | $2.18T | 37.25 | 24.29% | ― | 10.99% | 91.61% | |
59 Neutral | $30.02B | 0.85 | -18.80% | 4.01% | 2.14% | -50.70% | |
48 Neutral | $77.27B | 13.49 | 8.02% | 0.35% | -2.23% | ― |